A recent study found antibodies associated with RA and SLE in hospital patients with severe COVID-19. Additionally, one third of long Covid patients included in the study were observed to have elevated levels of autoantibodies for months post initial-infection.
Read More »Researchers at the Mayo Clinic ran a retrospective, comparative, multi-center study to determine if specific RA phenotypes may be responsible for poor COVID-19 outcomes.
Read More »A new study investigated how effective a two-dose SARS-CoV-2 vaccine regimen is for patients receiving Rituximab. Researchers measured the humoral and cellular immune responses, which correlate to antibody and T-cell production, respectively.
Read More »A recent study, published in Epidemiology, analyzed trends in patients with systemic autoimmune rheumatic diseases (SARDs) from the first COVID-19 wave through the initial Omicron wave. Their goal was to investigate how trends of incidence and severity of COVID-19 in those with SARDs have changed over time.
Read More »